GenVec, Inc. (GNVC) Stock News, Earnings & History

(NASDAQ:GNVC) Healthcare

Enjoy Interactive Tools and Indicators

52wk high: 2.78
52wk low: 0.63
EPS: -1.08
P/E: N/A
Div Rate: N/A
Yield: N/A
Market Cap: 9.06M
Avg Vol (3m): 67,346

Latest Headlines

More Articles About GNVC →

Company On Twitter

Company Profile

GenVec, Inc. is a biopharmaceutical company developing novel therapeutic drugs and vaccines. The Company specializes in the treatment of cancers, including pancreatic cancer, esophageal cancer, rectal caner, and head and neck cancer. The Company is also involved in studies involving hearing loss and balance disorders. GenVec also develops vaccines for infectious diseases.


Investor Relations | Press Releases

Insider Trading Cheat Sheet

No insider trading data available for GenVec, Inc..

Yahoo, HV, Market Watch, The Wall St. Journal